{
  "trial_id": "NCT01726582",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, performance status (ECOG), diagnosis confirmation (biopsy-proven adenocarcinoma), resectability status (resectable or borderline resectable), organ and bone marrow function (total leukocytes, absolute neutrophil count, hemoglobin, platelets, creatinine clearance, creatinine, bilirubin, AST/SGOT, ALT/SGPT), CA19-9 levels, previous chemotherapy or chemoradiation history, comorbidities, HIV/HBV/HCV status, pregnancy status, contraception use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Categorical",
          "performance status (ECOG)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "diagnosis confirmation (biopsy-proven adenocarcinoma)",
        "resectability status (resectable or borderline resectable)",
        "organ and bone marrow function (total leukocytes, absolute neutrophil count, hemoglobin, platelets, creatinine clearance, creatinine, bilirubin, AST/SGOT, ALT/SGPT)",
        "CA19-9 levels",
        "previous chemotherapy or chemoradiation history",
        "comorbidities",
        "HIV/HBV/HCV status",
        "pregnancy status",
        "contraception use."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Performance Status, Tumor Resectability Status, Baseline CA19-9 Levels, Baseline Hemoglobin, Baseline Platelet Count, Baseline Creatinine Clearance, Baseline Bilirubin, Baseline AST, Baseline ALT,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Performance Status",
        "Tumor Resectability Status",
        "Baseline CA19-9 Levels",
        "Baseline Hemoglobin",
        "Baseline Platelet Count",
        "Baseline Creatinine Clearance",
        "Baseline Bilirubin",
        "Baseline AST",
        "Baseline ALT"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Body Mass Index, Hemoglobin, Absolute Neutrophil Count, Platelet Count, Creatinine Clearance, Bilirubin, Aspartate Transaminases, Alanine Transaminases, CA19-9, Tumor Size, Tumor Location, Tumor Stage, Resectability Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Body Mass Index",
        "Hemoglobin",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Creatinine Clearance",
        "Bilirubin",
        "Aspartate Transaminases",
        "Alanine Transaminases",
        "CA19-9",
        "Tumor Size",
        "Tumor Location",
        "Tumor Stage",
        "Resectability Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, Eastern Cooperative Oncology Group performance status, diagnosis of adenocarcinoma of the pancreas, biopsy-proven resectable or borderline resectable adenocarcinoma of the pancreas, total leukocytes, absolute neutrophil count (ANC), hemoglobin, platelets, creatinine clearance, bilirubin, aspartate transaminases (AST/SGOT), alanine transaminases (ALT/SGPT), Ca19-9, tumor size, tumor location, tumor-arterial abutment, superior mesenteric vein, portal vein or superior mesenteric-portal vein confluence narrowing, presence of extra-pancreatic disease, presence of metastatic disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Eastern Cooperative Oncology Group performance status",
        "diagnosis of adenocarcinoma of the pancreas",
        "biopsy-proven resectable or borderline resectable adenocarcinoma of the pancreas",
        "total leukocytes",
        "absolute neutrophil count (ANC)",
        "hemoglobin",
        "platelets",
        "creatinine clearance",
        "bilirubin",
        "aspartate transaminases (AST/SGOT)",
        "alanine transaminases (ALT/SGPT)",
        "Ca19-9",
        "tumor size",
        "tumor location",
        "tumor-arterial abutment",
        "superior mesenteric vein",
        "portal vein or superior mesenteric-portal vein confluence narrowing",
        "presence of extra-pancreatic disease",
        "presence of metastatic disease"
      ]
    }
  }
}